Has FDA warned about tirzepatide salt forms?

At the medical review dated above, FDA statements about semaglutide salt forms had been located but no equivalent categorical statement about a tirzepatide salt. The principle is the same: compounders may use only the active ingredient that meets the legal conditions, and the approved products use the base form.

Published August 27, 2026 · updated August 27, 2026 · regulatory and clinical facts last checked 2026-08-27 · medically reviewed by Dr. S. Shuwart, MD on August 27, 2026

Medically reviewed · August 27, 2026

Tirzepatide base vs salt forms: why it matters and how to ask

The approved tirzepatide products use the base form of the molecule. What a salt form is, why FDA has raised the issue for semaglutide, what is known for tirzepatide, and the question to put to a provider.

What “base” and “salt” mean

A drug molecule can be manufactured as the free base or combined with an acid or base to form a salt, which can change solubility and handling. For regulatory purposes the active ingredient in the approved product defines what a compounder may use: a pharmacy compounding from a bulk substance must use a substance that meets the statutory conditions, and a different salt is a different substance.

The semaglutide precedent

FDA stated that some compounders were using semaglutide sodium or semaglutide acetate, salt forms that differ from the base semaglutide in Ozempic and Wegovy, and that it was not aware of a basis for compounding with those salts. That statement is the reason “base vs salt” became a consumer question.

Tirzepatide

The approved tirzepatide products contain tirzepatide base. As of our last review we had not located an FDA statement identifying tirzepatide salt forms in compounded products, and this page will be updated if one appears. The question is still worth asking, because the answer tells you whether the provider and pharmacy know what they are compounding from and whether they will say.

How to ask

“What is the exact active ingredient your pharmacy uses for compounded tirzepatide, and is it tirzepatide base?” A provider that names the pharmacy and confirms the base form in writing has answered. One that does not know, or will not say, is recorded on this site as not disclosing the formulation. The Compounding Disclosure Index tracks this per provider.

Questions this page answers

Has FDA warned about tirzepatide salt forms?: At the medical review dated above, FDA statements about semaglutide salt forms had been located but no equivalent categorical statement about a tirzepatide salt. The principle is the same: compounders may use only the active ingredient that meets the legal conditions, and the approved products use the base form.

Sources

FDA: Medications containing semaglutide marketed for type 2 diabetes or weight loss (regulator)
FDA: Human drug compounding — bulk drug substances (regulator)

Educational information, not medical advice. Decisions about GLP-1 medication belong with you and a licensed clinician who knows your history. Compounded medications are not FDA-approved. Report an error.